Trazodone-induced delirium: case report.

Rev Colomb Psiquiatr (Engl Ed)

Department of Psychiatry and Mental Health, Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal.

Published: July 2021

Trazodone is used as an antidepressant in doses between 150 and 600 mg. At lower doses, it is commonly used to treat insomnia. There are few case reports about confusional symptoms as an undesirable side effect of this drug. We report a case of a patient who presented with delirium after prescription of trazodone 100 mg. She required hospitalisation but, shortly after discontinuation of trazodone, the symptoms disappeared without antipsychotic medication. Seven months after the episode, the patient remains asymptomatic.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rcp.2018.10.006DOI Listing

Publication Analysis

Top Keywords

trazodone-induced delirium
4
delirium case
4
case report
4
report trazodone
4
trazodone antidepressant
4
antidepressant doses
4
doses 150
4
150 600 mg
4
600 mg lower
4
lower doses
4

Similar Publications

Trazodone-induced delirium: case report.

Rev Colomb Psiquiatr (Engl Ed)

July 2021

Department of Psychiatry and Mental Health, Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal.

Trazodone is used as an antidepressant in doses between 150 and 600 mg. At lower doses, it is commonly used to treat insomnia. There are few case reports about confusional symptoms as an undesirable side effect of this drug.

View Article and Find Full Text PDF

Background: Tardive dystonia associated with antidepressant use is rare and often under-recognized. We had an experience with trazodone, which is used for delirium and insomnia prescribed in general hospital, inducing tardive dystonia.

Case Presentation: A 61-year-old Japanese woman had been treated for schizophrenia.

View Article and Find Full Text PDF

Occurrence of trazodone-induced delirium.

Int Clin Psychopharmacol

September 1998

Department of General Psychiatry, University Hospital of Psychiatry, Vienna, Austria.

Trazodone, a triazolepyridine derivate, is both chemically and pharmacologically distinct from other serotonin reuptake inhibitors and possesses antidepressant, anxiolytic and hypnotic activity. We observed trazodone-induced delirium in three depressed patients who also suffered from preexisting organic cerebral lesions (two cases) or thyroideal dysfunction (one case). The appearance of hallucinations, psychomotoric agitation, and cognitive changes after initiation of trazodone therapy and their prompt cessation after drug discontinuation led to the impression that these were drug-induced phenomena.

View Article and Find Full Text PDF

Three bulimic patients with major depressive episodes developed delirium after trazodone administration. These cases raise a question about the susceptibility of bulimic patients to developing delirium when treated with trazodone.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!